SandboxAQ Expands Alliance with Deloitte to Offer AI Simulation Software Solutions

Alliance to add focus for Large Quantitative Models (LQMs) which are the new frontier in AI with applications in biopharma, energy and other sectors

PALO ALTO, Calif., Feb. 10, 2025 /PRNewswire/ -- SandboxAQ today announced it has expanded its relationship with Deloitte to offer SandboxAQ's AI LQM simulation products and solutions along with Deloitte's services capabilities to organizations worldwide.

SandboxAQ's AQBioSim and AQChemSim solutions leverage Large Quantitative Models (LQMs) to accelerate product development across a broad range of sectors, including biopharma. Deloitte will augment these offerings with their data and life sciences experience combined with their deep business and technology acumen. This collaboration will help transform nearly every facet of healthcare and life sciences.

"SandboxAQ is excited to expand its long-standing strategic alliance with Deloitte, whose relationships with some of the world's largest organizations will accelerate the adoption of our quantitative AI technologies," said Andrew McLaughlin, Chief Operating Officer of SandboxAQ. "AI simulation with Large Quantitative Models represents the next evolution of AI and will have a transformative impact on how organizations create value for their customers in ways that Large Language Models cannot."

Using LQMs in collaboration with Deloitte's Atlas AI™ knowledge graph capabilities will allow SandboxAQ's scientists to automatically extract new clinical hypotheses from literature, highlighting only those most likely to be correct. With Atlas AI, Deloitte brings its engineering skills and industry experience

together to accelerate the drug discovery process. Deloitte's Atlas AI team and SandboxAQ will also collaborate with pharmaceutical companies and other organizations on data evaluation, exploratory data analysis, and AI model testing and evaluation to enhance the speed and accuracy of the drug discovery processes. Along the way, SandboxAQ's AI-powered molecular simulations will generate vast amounts of highly accurate, physics-based data, delivering new insights for drug development, target ID, and treatment response.

"With this expansion of our alliance, we're able to combine our extensive experience in life sciences, data, and research with SandboxAQ's leadership in AI simulation and Large Quantitative Models," said Aditya Kudumala, principal, Deloitte Consulting LLP.  "Together, we aim to advance drug discovery and materials science for leading academic, commercial, and public sector entities."

Organizations interested in this expanded Deloitte and SandboxAQ Alliance can contact [email protected].

About SandboxAQ
SandboxAQ is a B2B company delivering solutions at the intersection of AI and quantum techniques. The company's Large Quantitative Models (LQMs) deliver critical advances in life sciences, financial services, navigation, and other sectors. The company emerged from Alphabet Inc. as an independent growth-backed company funded by leading investors including funds and accounts advised by T. Rowe Price Associates, Inc., IQT, US Innovative Technology Fund, S32, Eric Schmidt, Breyer Capital, Marc Benioff, Thomas Tull, Paladin Capital Group, and others. For more information, visit http://www.sandboxaq.com.

As used in this document, "Deloitte" means Deloitte Consulting LLP, a subsidiary of Deloitte LLP. Please see www.deloitte.com/us/about for a detailed description of our legal structure. Certain services may not be available to attest clients under the rules and regulations of public accounting.

View original content to download multimedia:https://www.prnewswire.com/news-releases/sandboxaq-expands-alliance-with-deloitte-to-offer-ai-simulation-software-solutions-302371506.html

SOURCE SandboxAQ